DGAP-Adhoc: MeVis Medical Solutions AG: Raising forecast for the current fiscal year
|
DGAP-Ad-hoc: MeVis Medical Solutions AG / Key word(s): Change in Forecast
MeVis Medical Solutions AG: Raising forecast for the current fiscal year
01-Sep-2022 / 17:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Bremen, September 1, 2022 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading provider of medical imaging software, raises its forecast for the present fiscal year due to the positive business development:
- For fiscal year 2021/2022 (October 1, 2021 to September 30, 2022), revenues are now expected to increase significantly to € 17.5 million to € 18.0 million (previous forecast for fiscal year 2021/2022: stable revenues of € 16.0 million to € 16.5 million).
- For EBIT (earnings before interest and taxes), the forecast for fiscal year 2021/2022 (October 1, 2021 to September 30, 2022) is now expected to increase significantly to € 6.0 million to € 6.5 million (previous forecast for fiscal year 2021/2022: stable EBIT of € 4.0 million to € 4.5 million).
Reasons for the increased revenues are the positive business development with the customer Hologic both in the license and in the maintenance business and, in addition, the development services with various medical technology companies have also developed very positively.
Contact:
Kirchhoff, Marcus / CEO
01-Sep-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
MeVis Medical Solutions AG |
|
Caroline-Herschel-Str. 1 |
|
28359 Bremen |
|
Germany |
| Phone: |
+49 421 224 95 0 |
| Fax: |
+49 421 224 95 999 |
| E-mail: |
[email protected] |
| Internet: |
http://www.mevis.de |
| ISIN: |
DE000A0LBFE4 |
| WKN: |
A0LBFE |
| Listed: |
Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1433695 |
| |
| End of Announcement |
DGAP News Service |
1433695 01-Sep-2022 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
18,54 |
16,76 |
18,07 |
17,13 |
16,21 |
18,76 |
17,34 |
| EBITDA1,2 |
9,18 |
7,60 |
8,25 |
5,97 |
4,77 |
7,99 |
3,99 |
| EBITDA-Marge3 |
49,51 |
45,35 |
45,66 |
34,85 |
29,43 |
42,59 |
|
| EBIT1,4 |
7,96 |
6,69 |
8,00 |
5,81 |
4,64 |
7,90 |
3,89 |
| EBIT-Marge5 |
42,93 |
39,92 |
44,27 |
33,92 |
28,62 |
42,11 |
22,43 |
| Jahresüberschuss1 |
5,62 |
7,17 |
8,07 |
5,70 |
4,55 |
7,79 |
4,92 |
| Netto-Marge6 |
30,31 |
42,78 |
44,66 |
33,27 |
28,07 |
41,52 |
28,37 |
| Cashflow1,7 |
7,32 |
5,52 |
6,55 |
2,89 |
9,13 |
4,86 |
5,85 |
| Ergebnis je Aktie8 |
3,09 |
3,94 |
4,43 |
3,13 |
2,50 |
4,28 |
2,70 |
| Dividende8 |
0,95 |
0,95 |
0,95 |
0,95 |
0,95 |
0,95 |
0,95 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Deloitte
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| MeVis Med. Solutions |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A0LBFE |
25,400 |
Halten |
46,23 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 10,58 |
10,27 |
1,03 |
7,74 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 2,59 |
7,90 |
2,67 |
10,79 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,95 |
0,95 |
3,74 |
19.03.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| - |
27.05.2024 |
- |
29.01.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| 2,82% |
-5,52% |
0,79% |
-23,95% |
|
|
MeVis Medical Solutions AG DE000A0LBFE4